Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Protagonist Therapeutics Inc (NASDAQ: PTGX) closed the day trading at $44.37 down -1.40% from the previous closing price of $45.00. In other words, the price has decreased by -$1.40 from its previous closing price. On the day, 0.79 million shares were traded. PTGX stock price reached its highest trading level at $45.325 during the session, while it also had its lowest trading level at $43.41.
Ratios:
For a better understanding of PTGX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.32. For the most recent quarter (mrq), Quick Ratio is recorded 13.73 and its Current Ratio is at 13.73. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on September 24, 2024, initiated with a Buy rating and assigned the stock a target price of $65.
On September 09, 2024, Truist started tracking the stock assigning a Buy rating and target price of $60.
On October 30, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $32.CapitalOne initiated its Overweight rating on October 30, 2023, with a $32 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when Ali Asif sold 14,203 shares for $44.49 per share. The transaction valued at 631,872 led to the insider holds 34,960 shares of the business.
Waddill William D. sold 8,000 shares of PTGX for $360,000 on Sep 10 ’24. The Director now owns 12,000 shares after completing the transaction at $45.00 per share. On Sep 11 ’24, another insider, Ali Asif, who serves as the Officer of the company, bought 14,203 shares for $44.49 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTGX now has a Market Capitalization of 2613596928 and an Enterprise Value of 2060570496. As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.19 while its Price-to-Book (P/B) ratio in mrq is 4.82. Its current Enterprise Value per Revenue stands at 6.457 whereas that against EBITDA is 13.449.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $48.00, while it has fallen to a 52-week low of $13.72. The 50-Day Moving Average of the stock is 6.14%, while the 200-Day Moving Average is calculated to be 39.69%.
Shares Statistics:
Over the past 3-months, PTGX traded about 907.34K shares per day on average, while over the past 10 days, PTGX traded about 928480 shares per day. A total of 57.71M shares are outstanding, with a floating share count of 55.65M. Insiders hold about 5.52% of the company’s shares, while institutions hold 96.79% stake in the company. Shares short for PTGX as of 1726185600 were 3229183 with a Short Ratio of 3.56, compared to 1723680000 on 3100480. Therefore, it implies a Short% of Shares Outstanding of 3229183 and a Short% of Float of 5.56.